Hartmut Link

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations

Medicine, Oncology, Pharmacology +9

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

Norbert Schmitz, Peter Dreger, David C. Linch et al. · The Lancet · 1996 · 617 citations

Medicine, Hematology, Oncology +14

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

Pierre Fenaux, M. Le Deley, Sylvie Castaigné et al. · Blood · 1993 · 519 citations · Full text

Medicine, Hematology, Oncology +9

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

Ralf‐Dieter Hofheinz, Frederik Wenz, Stefan Post et al. · The Lancet Oncology · 2012 · 507 citations

Medicine, Oncology, Chemotherapy +12